Background: Chronic inflammation plays an important role in the development of cardiovascular risk factors. Although the prevalence of comorbidities and cardiovascular events has been described in patients with psoriasis, few studies have examined subclinical atherosclerosis in psoriasis patients. Objective: Our objective was to investigate the prevalence of atheroma plaques in patients with severe psoriasis compared with control subjects and to analyze the association with metabolic syndrome, homocysteine levels and inflammatory parameters. Patients and Methods: This case-control study included 133 patients, 72 with psoriasis and 61 controls consecutively admitted to the outpatient clinic in Dermatology Departments (Granada, Spain.) Results: Carotid atheroma plaques were observed in 34.7% of the psoriatic patients versus 8.2% of the controls (p=0.001) and metabolic syndrome was diagnosed in 40.3% of the psoriatic patients versus 13.1% of the controls (p<0.001). Significantly higher mean values of insulin, aldosterone, homocysteine and acute phase parameters (fibrinogen, D-dimer, C reactive protein and erythrocyte sedimentation rate) were found in psoriatic patients. Binary logistic regression showed a strong association between psoriasis and atheroma plaque and metabolic syndrome after controlling for confounding variables. Limitations: The absence of longitudinal quantification of metabolic syndrome parameters and intima-media thickness in psoriatic patients. Conclusion: The chronic inflammation and hyperhomocysteinemia found in psoriatic patients may explain the association with atheroma plaque and metabolic syndrome. Cardiovascular screening by metabolic syndrome criteria assessment and carotid ultrasound in psoriasis may be useful to detect individuals at risk and start preventive treatment against the development of cardiovascular disease.
ATP-III
soriasis is a chronic, immune-mediated inflammatory skin disease that affects 2-3% of the general population [1] . Psoriasis involves the innate and acquired immune systems with an imbalance Th1/Th2 in favor of a Th1 pattern. Recent advances in immunopathogenesis and the genetics of psoriasis have shifted the focus from a single organ disease confined to the skin to a systemic inflammatory condition. Similarly to other immune disorders, patients with psoriasis have an increased risk of developing cardiovascular disease and metabolic syndrome [2] . Recent research has shown that chronic and systemic inflammation plays a major role in the development of atherosclerosis [3] and there are striking similarities between the molecular and inflammatory pathways in psoriasis and atherosclerosis [4] . Although the prevalence of comorbidities and cardiovascular events has been described in patients with psoriasis versus control populations [5, 6] , few studies have examined subclinical atherosclerosis in patients with psoriasis [7, 8] artery intima-media thickness (IMT) in patients without risk factors and also it has been suggested that the carotid artery IMT does not always correlate with atherosclerosis, particularly in relatively young individuals with chronic inflammatory disease [9] . Some authors even found that myocardial infarction was more closely correlated with atheroma plaque than with the intima-media thickness [10] . The relative impact of systemic inflammation related to psoriasis on vascular lesions and cardiovascular risk nonetheless remains poorly understood. The end point of this case-control study was to investigate the prevalence of carotid atheromatosis (atheroma plaque) in patients with severe psoriasis in comparison with control subjects and to analyze the association with metabolic syndrome (MS), homocysteine levels and inflammatory parameters.
Material and methods

Patients and controls
This case-control study included 133 outpatients, 72 with severe psoriasis (PASI and BSA>10) and 61 controls with other dermatological diseases other than psoriasis (mainly nevi, seborrheic keratosis, actinic keratosis or verruca, as reported in other similar studies [11] ) from the Dermatology Department of San Cecilio University Hospital, Granada (Spain). Psoriatic and control groups were enrolled during the same time period. No significant differences were recorded according to sex of patients or controls (p=0.70). Diagnosis of psoriasis was based on clinical findings. Inclusion criteria were: age >18 years for males and females, presence of plaque or erythrodermic severe psoriasis with PASI and BSA higher than 10, without systemic treatment in the last 2 months and signing of informed consent to study participation. Exclusion criteria were: cutaneous lymphomas or other cancers except for non-melanoma skin cancer. Inclusion criteria for controls were: age >18 years for males and females and signing of informed consent to study participation. Exclusion criteria for controls were the same as described above and the presence of psoriasis. The study was approved by the Ethics Committee of San Cecilio University Hospital and written informed consent was obtained from all patients and controls, according to Helsinki Declaration.
Clinical and laboratory parameters and Doppler ultrasound examination
The severity of psoriasis was determined by application of the Psoriasis Area Severity Index (PASI) and the Body Surface Area (BSA). The weight, height and abdominal circumference of subjects were measured, and their body mass index (BMI, kg/m 2 ) was calculated. Systolic and diastolic blood pressure (BP) was measured after a 5-min rest and again 10 min later, recording the mean value. Serum aldosterone, triglycerides, HDL-C, LDL-C, total cholesterol, blood glucose, insulin, D-dimer, fibrinogen, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), homocysteine and folic acid levels were studied in samples drawn between 8 and 9 am after a rest period of ≥30 min. The homeostasis model assessment of insulin resistance (HOMA-IR index, U/mg) was calculated (fasting insulin×fasting glucose/22.5). Data were also gathered on age, sex, personal or family history of early cardiovascular disease (<55 yrs in father and <65 yrs in mother), personal history of psoriatic arthritis or nail psoriasis, mean time with psoriasis, alcoholism (>40 g/day), smoking (>5 cigarettes/day), sedentarism (physical exercise <30 min/day), diet (sodium intake) and drug intake (antihypertensives, diuretics, hypocholesterolemics or oral antidiabetics). Prevalence of metabolic syndrome was calculated according to ATP-III criteria; MS was defined by the presence of three of the following [12] : abdominal circumference >102 cm in males and >88 cm in females; hypertriglyceridaemia >150 mg/dL, HDLcholesterol <40 mg/dL in males and <50 mg/dL in females, blood pressure >130/85 mmHg or blood glucose >110 mg/dL. Subjects underwent Doppler ultrasound examination with Acuson Antares equipment (Siemens, Berlin, Germany), using 5-10 MHZ transducer with supra-aortic trunk programme and recording with M mode the presence of atheroma plaques (intima-media thickness >1.5 cm) in common carotids, carotid bulb and internal and external carotids. The bilateral common carotids were scanned longitudinally to measure the intima-media thickness (IMT). Images were obtained from the distal portion of the common carotid artery, 1 to 2 cm proximal to the carotid bulb recording a mean value in left and right side. The two bright echogenic lines in the arterial wall were identified as the intima and media lines. The IMT was measured as the distance from the main edge of the lumen-intima interface to the media-adventitia interface of the carotids ( figure 1 ). Patients and controls were examined in supine or semi-supine position, with the neck extended and the chin turned contralateral to the side being examined. The Doppler system was also used to detect carotid flow anomalies. All ultrasonographic measurements were obtained by a single radiologist and all images of the carotid arteries were recorded on the hard disk of the ultrasound system for subsequent analysis and evaluated by an independent A B Figure 1 . Doppler ultrasound examination.
A) The two bright echogenic lines in the arterial wall were identified as the intima and media lines. The IMT was measured as the distance from the main edge of the lumen-intima interface to the media-adventitia interface of the carotids. B) Atheroma plaque in a patient with psoriasis (arrow). Table 2 . Analysis of the ATP-III metabolic syndrome criteria (mean, SD) in men and women with psoriasis and their respective controls. Also LDL-C, total cholesterol, Total Cholesterol/HDL and LDL-C/HDL-C values are listed. Acute phase reactants 
Discussion
The results of this study confirm the association between severe psoriasis and a higher cardiovascular risk in both male and female groups. We found a higher prevalence of 342 subclinical carotid atheromatosis (atheroma plaques) and MS (ATP-III criteria) in patients with psoriasis than in control subjects. Binary logistic regression showed a strong association between psoriasis and atheroma plaque and metabolic syndrome after controlling for confounding variables. The prevalence of these cardiovascular risk factors differs slightly between male and female patients with psoriasis.
Metabolic syndrome
Many studies have demonstrated an increased risk for all the components of metabolic syndrome among patients with psoriasis, based on huge computerized medical databases and this may be problematic due to information bias regarding documentation of the diagnosis of psoriasis and its comorbidities [13] . A recent study showed that only 57% of patients with a registered diagnosis of psoriasis in the computerized medical records had a true diagnosis of psoriasis [14] and most computerized medical records do not compel the physician to input data regarding some parameters such as obesity, body mass index or smoking habits.
We found a higher prevalence of MS in patients with psoriasis than in their respective control groups. Few studies have analyzed the prevalence of MS not based on computerized medical databases [11, 15] . Comparison of published prevalence for different populations is difficult if different diagnostic criteria are used. Studies have reported a MS prevalence of 7.5-20% in the general population [16] , within the range observed in our controls. The importance of metabolic syndrome is that it may confer a cardiovascular risk higher than the individual components, subjects who met ATP-III MS criteria had a 2.59-fold greater likelihood (OR=2.59) of a cardiovascular event in the next 10 yrs [17] . In our study, patients with MS had a 3.5-fold higher risk (OR=3.5, 95% CI: 1.2 -9.7) of the presence of atheroma plaque. A higher mortality risk for arterial and venous thrombosis and a higher risk of myocardial infarction, especially in young patients with severe psoriasis, has been described [18] . In the present study, a higher mean BMI and abdominal circumference were found in psoriatic patients than in controls. This indicates that psoriatic patients undergo an abdominal redistribution of fat, which is considered an important cardiovascular risk factor and was associated in our study with higher insulin resistance, a key element in the MS. We did not find differences between cases and controls regarding mean levels of blood glucose or lipid levels. In contrast to our findings, others studies showed that diabetes mellitus type 2 and an atherogenic lipid profile ocurred significantly more frequently in patients with psoriasis than in controls [15, 19] . Despite the fact that the association with hypertension has not been completely supported by all of the current literature [1] , we found that patients with psoriasis presented higher mean levels of systolic and diastolic BP.
Carotid atheromatosis
We found a significantly higher prevalence of carotid atheromatosis in the male and female psoriatic patients than in controls. The prevalence of atheroma plaque as a marker of subclinical atherosclerosis has not been properly studied in patients with psoriasis. Most studies directly analyse cardiovascular events, e.g., myocardial infarction [20, 21] , with the potential bias of only considering those who survive heart disease. The presence of the majority of parameters that constitute MS were positively related to the presence of atheroma plaque in this study. Only two reports analyzed the prevalence of carotid atheroma plaque and IMT in patients with psoriasis, excluding patients with risk factors, without finding significant differences [7, 8] . Impaired endothelial function and increased IMT of the carotid arteries in psoriatic arthritis have also been reported [22] . In this study psoriasis was associated with atheroma plaque even after controlling for confounding parameters and metabolic syndrome in a multivariate analysis. IMT was also significantly higher in patients with psoriasis and correlated with psoriasis activity (PASI) and age in multiple linear regression analysis. So, older patients with severe psoriasis need frequent follow-up to reduce cardiovascular morbidity. Detection of subclinical atherosclerosis and identification of patients at risk for developing atherosclerosis are important for the prevention of cardiovascular disease. Systemic inflammation has been associated with the development of atherosclerosis, which suggests that psoriatic patients may have a higher risk for cardiovascular disease, also metabolic syndrome parameters and treatments may contribute to the development of atherosclerosis in these patients. Both diseases share common inflammatory cytokine profiles, locally and systemically [23] . The metabolic aspects of chronic Th-1 and Th-17 inflammation in psoriasis have the potential to impact other conditions, such as risk factors and atherosclerosis but inflammatory cytokines and hormones produced in conditions such as obesity, insulin resistance or atherosclerosis may also promote a pro-inflammatory state.
Hormonal study
Patients with psoriasis presented significantly higher insulin levels and hyperinsulinemia, defined as an insulin level >10.0 U/mL, was significantly higher in psoriatic patients than in controls. However, the HOMA-IR index did not show differences between the groups, maybe because glucose levels were very similar in patients and in controls. Given that a proportion of patients with psoriasis are obese and abdominal obesity is strongly associated with the development of metabolic syndrome, the relationship between psoriasis and insulin resistance is not unexpected. No differences in blood glucose were found, presumably because of the number of patients involved in the study, but hyperinsulinemia may reflect a trend to develop glucose intolerance in the future. Also, insulin levels correlated positively with all the metabolic syndrome parameters, aldosterone and PASI. Aldosterone, a mineralocorticoid hormone classically involved in sodium balance regulation and hypertension [24] , is increased in patients with metabolic syndrome [25] [26] [27] [28] associated with insulin resistance, as found in the present study.
Patients with psoriasis presented significantly higher levels of plasma homocysteine without differences in folic acid. Homocysteine correlated positively with psoriasis activity (r=0.34, p=0.02), inflammation (CRP, r=0.29, p=0.01) and mean IMT (r=0.28, p=0.036). Clinical and epidemiological studies have provided strong evidence that plasma homocysteine is an independent risk factor for atherosclerotic diseases including coronary artery disease, stroke and peripheral vascular disease [29] . There have been several studies that investigated homocysteine levels in psoriasis patients with different results. Reduced plasma folate levels in patients with psoriasis, which results from reduced absorption from the gut or increased vitamin utilization in the skin, have been one of several explanations for this hyperhomocysteinemia found in patients with psoriasis [30] [31] [32] [33] . In the present case, folic acid correlated negatively with PASI, but no significant differences were found between patients and controls. The mechanisms of hyperhomocysteinemia for the development of atherothrombosis are endothelial injury, increased platelet turnover, enhanced platelet activation with increased thromboxane synthesis, oxidative modification of low-density lipoproteins and endothelial-leucocyte interactions [34] . Dietary supplementation with folic acid and vitamins B6 and B12 appears to be a reasonable and safe therapeutic option in these patients [30] .
Acute phase reactants
Mean CRP, fibrinogen, D-dimer and ESR (only in females) values were significantly higher in psoriatic patients versus their controls, and these parameters were related to MS and carotid atheromatosis. PASI, BSA and IMT were positively correlated with all acute phase parameters. Chronic inflammation was found to play an important role in the development of insulin resistance, endothelial dysfunction and cardiovascular disease [35] and other studies report that plasma acute-phase protein levels (C-reactive protein or fibrinogen) were significantly elevated in patients with psoriasis compared with healthy controls [36] . The Th-1 and Th-17 pro-inflammatory situation underlying psoriasis, and shown by higher mean values of acute phase reactants, may have a potential impact in other conditions, such as obesity, diabetes, thrombosis, or atherosclerosis.
Although case-control studies can show a possible selection bias, the distribution of the potentially confounding factors as age, sex, tobacco use, sedentarism and drug intake were homogeneous in the two groups. In the present study, the binary logistic regression model showed a higher risk for MS and atheroma plaque in patients with psoriasis, after controlling for multiple confounding factors. Also, case-control studies do not allow the directionality of the association to be ascertained, so more prospective studies with larger numbers of patients are required to analyze the pathogenic mechanisms underlying the increase in cardiovascular risk in patients with psoriasis.
In conclusion, the results obtained indicate an association between psoriasis in males and females and the cardiovascular risk factors of MS and carotid atheromatosis. Our data show that the presence of psoriasis was an independent risk factor for subclinical atherosclerosis (atheroma plaque and higher IMT) and metabolic syndrome, possibly due to chronic inflammation and hyperhomocysteinemia. Cardiovascular screening by MS criteria assessment and carotid ultrasound in males or females with psoriasis may be useful to detect individuals at risk and start preventive treatment against the development of cardiovascular disease.
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